Amersham, United Kingdom

Antonios Danikas

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonios Danikas: Innovator in Therapy Selection Methods

Introduction

Antonios Danikas is a notable inventor based in Amersham, GB. He has made significant contributions to the field of medical imaging and therapy selection, particularly for patients suffering from Barrett's oesophagus. His innovative approach aims to enhance treatment options when conventional therapies have failed.

Latest Patents

Antonios Danikas holds a patent for a therapy selection method. This invention relates to a method that assists in determining therapy for patients with Barrett's oesophagus, especially when first-line therapy has been unsuccessful and dysplasia has been diagnosed. The method utilizes an imaging agent that targets specific receptors, including Her2, cMet, guanylyl cyclase, and IGF1R. This imaging agent is suitable for both radioisotope and optical imaging, preferably in vivo.

Career Highlights

Danikas is currently associated with GE Healthcare, where he continues to work on innovative solutions in healthcare technology. His expertise in imaging and therapy selection has positioned him as a valuable asset in the medical field.

Collaborations

Throughout his career, Antonios has collaborated with esteemed colleagues, including Clifford Smith and Ian Andrew Wilson. These partnerships have fostered a collaborative environment that encourages innovation and the development of new technologies.

Conclusion

Antonios Danikas is a pioneering inventor whose work in therapy selection methods has the potential to significantly impact patient care in the field of gastroenterology. His contributions to medical imaging and collaboration with other professionals highlight his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…